Treatment of trastuzumab-resistant HER2-positive metastatic breast cancer: a case report.
10.3760/cma.j.cn112152-20220620-00437
- Author:
Fan WU
1
;
Mu Lan CHEN
1
;
Wei Wei HUANG
1
;
Jian LIU
1
Author Information
1. Department of Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350000, China.
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Initumumab;
Primary drug resistance;
Pyrrotinib
- MeSH:
Humans;
Female;
Trastuzumab/therapeutic use*;
Breast Neoplasms/pathology*;
Receptor, ErbB-2;
Antibodies, Monoclonal, Humanized/therapeutic use*;
Neoplasms, Second Primary;
Drug Resistance, Neoplasm
- From:
Chinese Journal of Oncology
2022;44(12):1390-1392
- CountryChina
- Language:Chinese